Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Cerebellar Ataxia Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 36
Abbreviations 36
Definitions 36
Research Methodology 37
Secondary Research 37
About GlobalData 38
Contact Us 38
Source 38
List of Tables
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Region, 2017* 6
Cerebellar Ataxia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Cerebellar Ataxia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 9
Cerebellar Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Cerebellar Ataxia Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 12
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 15
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 16
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 17
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Phase, 2017* 18
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 19
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Cerebellar Ataxia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Cerebellar Ataxia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26
List of Figures
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Cerebellar Ataxia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Cerebellar Ataxia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 9
Cerebellar Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 12
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 15
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 16
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 17
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 19
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Cerebellar Ataxia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Cerebellar Ataxia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26
GlobalData Methodology 37
